Technical Analysis for BIEI - Premier Biomedical

Grade Last Price % Change Price Change
grade F 0.001 0.00% 0.0000
BIEI closed unchanged on Tuesday, August 4, 2020, on 25 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BIEI trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Older signals for BIEI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically focusing the treatment of Cancer, Multiple Sclerosis (MS), Neuropathic Pain, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Fibromyalgia, Traumatic Brain Injury (TBI), Alzheimer's disease (AD), and Blood Sepsis and Viremia. The Company intends to develop its Sequential-Dialysis Technique, to target Cancer, Alzheimer's disease, ALS, Blood Sepsis, Leukemia and other life-threatening cancers. The Sequential-Dialysis Technique is a methodology for the removal of those molecules, which are harmful and responsible for causing diseases. Its Sequential-Dialysis Technique method removes those excitatory neural transmitters that cause the death of those cells. It also intends to develop Feldetrex, a candidate drug, for the treatment of MS, Fibromyalgia and TBI. Feldetrex utilizes a low dosage of Naltrexone to increase endogenous enkephalins10.
Medicine Medical Specialties RTT Cancer Pain Diseases Treatment Of Cancer Cancers Dialysis Multiple Sclerosis Alzheimer's Disease Leukemia Fibromyalgia Amyotrophic Lateral Sclerosis Ms Sepsis Traumatic Brain Injury Als

Is BIEI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.034
52 Week Low 0.0002
Average Volume 12,243,969
200-Day Moving Average 0.0011
50-Day Moving Average 0.0013
20-Day Moving Average 0.0012
10-Day Moving Average 0.0011
Average True Range 0.0008
ADX 7.19
+DI 22.5806
-DI 22.5806
Chandelier Exit (Long, 3 ATRs ) -0.0009
Chandelier Exit (Short, 3 ATRs ) 0.0033
Upper Bollinger Band 0.0014
Lower Bollinger Band 0.0010
Percent B (%b) 0.0
BandWidth 33.3333
MACD Line -0.0003
MACD Signal Line -0.0001
MACD Histogram -0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0012
Resistance 3 (R3) 0.0012 0.0011 0.0011
Resistance 2 (R2) 0.0011 0.0011 0.0011 0.0011
Resistance 1 (R1) 0.0011 0.0011 0.0011 0.0011 0.0011
Pivot Point 0.0010 0.0010 0.0010 0.0010 0.0010
Support 1 (S1) 0.0010 0.0010 0.0010 0.0010 0.0009
Support 2 (S2) 0.0009 0.0010 0.0009 0.0009
Support 3 (S3) 0.0009 0.0009 0.0009
Support 4 (S4) 0.0009